Cargando...
Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?
Therapeutics and vaccines against the COVID-19 pandemic need to be developed rapidly and efficiently, given its severity. To maximize the efficiency and productivity of drug development, the world has adopted disruptive technologies and approaches in various drug development areas. Telehealth, chara...
Guardado en:
| Publicado en: | Int J Mol Sci |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8196831/ https://ncbi.nlm.nih.gov/pubmed/34064287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22115457 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|